Top

Reviews in Endocrine and Metabolic Disorders

Published in:

01-12-2019 | Insulins

Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases

Authors: Matthieu Minty, Thibault Canceil, Matteo Serino, Remy Burcelin, François Tercé, Vincent Blasco-Baque

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2019

Abstract

It has recently become evident that the periodontium (gingiva, desmodontal ligament, cementum and alveolar bone) and the associated microbiota play a pivotal role in regulating human health and diseases. The oral cavity is the second largest microbiota in the body with around 500 different bacterial species identified today. When disruption of oral cavity and dysbiosis occur, the proportion of strict anaerobic Gram-negative bacteria is then increased. Patients with periodontitis present 27 to 53% more risk to develop diabetes than the control population suggesting that periodontitis is an aggravating factor in the incidence of diabetes. Moreover, dysbiosis of oral microbiota is involved in both periodontal and metabolic disorders (cardiovascular diseases, dyslipidaemia …). The oral diabetic dysbiosis is characterized by a specific bacteria Porphyromonas, which is highly expressed in periodontal diseases and could exacerbate insulin resistance. In this review, we will address the nature of the oral microbiota and how it affects systemic pathologies with a bidirectional interaction. We also propose that using prebiotics like Akkermansia muciniphila may influence oral microbiota as novel therapeutic strategies. The discovery of the implication of oral microbiota for the control of metabolic diseases could be a new way for personalized medicine.

Pischon T, Hu F, Rexrode K, Girman C, Manson J, Rimm E. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis. 2008;197:392–9.CrossRefPubMed

Firatli E. The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol. 1997;68:136–40.CrossRefPubMed

D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani A, Deanfield J. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93:3989–94.CrossRefPubMed

Vergnes JN, Kaminski M, Lelong N, Musset AM, Sixou M, Nabet C. Maternal dental caries and pre-term birth: results from the EPIPAP study. Acta Odontol Scand. 2011.

Löe H. Care. D. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329–34.CrossRefPubMed

Soell M, Hassan M, Miliauskaite A, Haïkel Y, Selimovic D. The oral cavity of elderly patients in diabetes. Diabetes Metab. 2007;33(Suppl 1):S10–8.CrossRefPubMed

Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol. 1986;1:48–57.CrossRefPubMed

Doan N, Contreras A, Flynn J, Morrison J, Slots J. Proficiencies of three anaerobic culture systems for recovering periodontal pathogenic bacteria. J Clin Microbiol. 1999;37:171–4.CrossRefPubMedPubMedCentral

Saito T, Shimazaki Y. Metabolic disorders related to obesity and periodontal disease. Periodontol. 2007;43:254–66.CrossRef

10.

Hettne K, Weeber M, Laine M, Ten Cate H, Boyer S, Kors J. Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol. 2007;34:1016–24.CrossRefPubMed

11.

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.CrossRefPubMed

12.

Shoelson S, Lee J, Goldfine A. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–801.CrossRefPubMedPubMedCentral

13.

Preshaw PM, Bissett SM. Periodontitis: oral complication of diabetes. Endocrinol Metab Clin N Am. 2013;42(4):849–67. https://doi.org/10.1016/j.ecl.2013.05.012.CrossRef

14.

Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000. 2006;40:11–28. https://doi.org/10.1111/j.1600-0757.2005.00141.x.CrossRefPubMed

15.

Preshaw PM. Antibiotics in the treatment of periodontitis. Dent Update. 2004;31(8):448 -50, 53-4, 56.CrossRefPubMed

16.

Taylor JJ, Preshaw PM. Gingival crevicular fluid and saliva. Periodontol 2000. 2016;70(1):7–10. doi:https://doi.org/10.1111/prd.12118.CrossRef

17.

Foster BL. On the discovery of cementum. J Periodontal Res. 2017;52(4):666–85. https://doi.org/10.1111/jre.12444.CrossRefPubMedPubMedCentral

18.

de Jong T, Bakker AD, Everts V, Smit TH. The intricate anatomy of the periodontal ligament and its development: lessons for periodontal regeneration. J Periodontal Res. 2017;52(6):965–74. https://doi.org/10.1111/jre.12477.CrossRefPubMed

19.

Preshaw PM, Foster N, Taylor JJ. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000. 2007;45:138–157. doi:https://doi.org/10.1111/j.1600-0757.2007.00221.x.CrossRefPubMed

20.

Tsuboi K, Hasegawa T, Hongo H, Yurimoto H, Kobayashi S. [Bone Cell Biology Assessed by Microscopic Approach. Novel insights about bone tissue by new microscopy systems]. Clin Calcium. 2015;25(10):1505–11. doi: CliCa151015051511.

21.

Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015;2015:421746. https://doi.org/10.1155/2015/421746.CrossRefPubMedPubMedCentral

22.

Listgarten MA, Loomer PM. Microbial identification in the management of periodontal diseases. A systematic review. Ann Periodontol. 2003;8(1):182–92. https://doi.org/10.1902/annals.2003.8.1.182.CrossRefPubMed

23.

Field CA, Gidley MD, Preshaw PM, Jakubovics N. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes. J Periodontal Res. 2012;47(4):470–8. https://doi.org/10.1111/j.1600-0765.2011.01455.x.CrossRefPubMed

24.

Preshaw PM, Walls AW, Jakubovics NS, Moynihan PJ, Jepson NJ, Loewy Z. Association of removable partial denture use with oral and systemic health. J Dent. 2011;39(11):711–9. https://doi.org/10.1016/j.jdent.2011.08.018.CrossRefPubMed

25.

Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol. 2007;149(2):217–25. https://doi.org/10.1111/j.1365-2249.2007.03441.x.CrossRefPubMedPubMedCentral

26.

Blasco-Baque V, Garidou L, Pomie C, Escoula Q, Loubieres P, Le Gall-David S, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2017;66(5):872–85. https://doi.org/10.1136/gutjnl-2015-309897.CrossRefPubMed

27.

Fak F, Tremaroli V, Bergstrom G, Backhed F. Oral microbiota in patients with atherosclerosis. Atherosclerosis. 2015;243(2):573–8. https://doi.org/10.1016/j.atherosclerosis.2015.10.097.CrossRefPubMed

28.

Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2017;23(3):276–86. https://doi.org/10.1111/odi.12509.CrossRefPubMed

29.

Al-Shehri SS, Sweeney EL, Cowley DM, Liley HG, Ranasinghe PD, Charles BG, et al. Deep sequencing of the 16S ribosomal RNA of the neonatal oral microbiome: a comparison of breast-fed and formula-fed infants. Sci Rep. 2016;6:38309. https://doi.org/10.1038/srep38309.CrossRefPubMedPubMedCentral

30.

Feres M, Teles F, Teles R, Figueiredo LC, Faveri M. The subgingival periodontal microbiota of the aging mouth. Periodontol 2000. 2016;72(1):30–53. doi:https://doi.org/10.1111/prd.12136.CrossRefPubMedPubMedCentral

31.

O'Dowd LK, Durham J, McCracken GI, Preshaw PM. Patients' experiences of the impact of periodontal disease. J Clin Periodontol. 2010;37(4):334–9. https://doi.org/10.1111/j.1600-051X.2010.01545.x.CrossRefPubMed

32.

Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973–4. https://doi.org/10.1001/jama.2015.4260.CrossRefPubMed

33.

Amiri AA, Maboudi A, Bahar A, Farokhfar A, Daneshvar F, Khoshgoeian HR, et al. Relationship between type 2 diabetic retinopathy and periodontal disease in Iranian adults. N Am J Med Sci. 2014;6(3):139–44. https://doi.org/10.4103/1947-2714.128476.CrossRefPubMedPubMedCentral

34.

LaMonte MJ, Williams AM, Genco RJ, Andrews CA, Hovey KM, Millen AE, et al. Association between metabolic syndrome and periodontal disease measures in postmenopausal women: the Buffalo OsteoPerio study. J Periodontol. 2014;85(11):1489–501. https://doi.org/10.1902/jop.2014.140185.CrossRefPubMed

35.

Poplawska-Kita A, Siewko K, Szpak P, Krol B, Telejko B, Klimiuk PA, et al. Association between type 1 diabetes and periodontal health. Adv Med Sci. 2014;59(1):126–31. https://doi.org/10.1016/j.advms.2014.01.002.CrossRefPubMed

36.

Pranckeviciene A, Siudikiene J, Ostrauskas R, Machiulskiene V. Severity of periodontal disease in adult patients with diabetes mellitus in relation to the type of diabetes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(1):117–23. https://doi.org/10.5507/bp.2013.098.CrossRefPubMed

37.

Sakalauskiene J, Kubilius R, Gleiznys A, Vitkauskiene A, Ivanauskiene E, Saferis V. Relationship of clinical and microbiological variables in patients with type 1 diabetes mellitus and periodontitis. Med Sci Monit. 2014;20:1871–7. doi:https://doi.org/10.12659/MSM.890879.CrossRefPubMedPubMedCentral

38.

Schjetlein AL, Jorgensen ME, Lauritzen T, Pedersen ML. Periodontal status among patients with diabetes in Nuuk. Greenland Int J Circumpolar Health. 2014;73:26093. https://doi.org/10.3402/ijch.v73.26093.CrossRefPubMed

39.

Ahmad A, Furuta M, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Association of periodontal status with liver abnormalities and metabolic syndrome. J Oral Sci. 2015;57(4):335–43. https://doi.org/10.2334/josnusd.57.335.CrossRefPubMed

40.

Alhabashneh R, Khader Y, Herra Z, Asa'ad F, Assad F. The association between periodontal disease and metabolic syndrome among outpatients with diabetes in Jordan. J Diabetes Metab Disord. 2015;14:67. https://doi.org/10.1186/s40200-015-0192-8.CrossRefPubMedPubMedCentral

41.

Iwasaki M, Sato M, Minagawa K, Manz MC, Yoshihara A, Miyazaki H. Longitudinal relationship between metabolic syndrome and periodontal disease among Japanese adults aged >/=70 years: the Niigata study. J Periodontol. 2015;86(4):491–8. https://doi.org/10.1902/jop.2015.140398.CrossRefPubMed

42.

Lee KS, Lee SG, Kim EK, Jin HJ, Im SU, Lee HK, et al. Metabolic syndrome parameters in adolescents may be determinants for the future periodontal diseases. J Clin Periodontol. 2015;42(2):105–12. https://doi.org/10.1111/jcpe.12338.CrossRefPubMed

43.

Adachi K, Mishiro T, Tanaka S, Yoshikawa H, Kinoshita Y. A study on the relationship between reflux esophagitis and periodontitis. Intern Med. 2016;55(18):2523–8. https://doi.org/10.2169/internalmedicine.55.6898.CrossRefPubMed

44.

Chen X, Xie L, Liu Y, Chen D, Yu Q, Gan X, et al. Metabolic syndrome and periodontal disease among civilian pilots. Aerosp Med Hum Perform. 2016;87(12):1016–20. https://doi.org/10.3357/AMHP.4654.2016.CrossRefPubMed

45.

Corlan Puscu D, Ciuluvica RC, Anghel A, Malaescu GD, Ciursas AN, Popa GV, et al. Periodontal disease in diabetic patients - clinical and histopathological aspects. Romanian J Morphol Embryol. 2016;57(4):1323–9.

46.

Furuta M, Liu A, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Tooth loss and metabolic syndrome in middle-aged Japanese adults. J Clin Periodontol. 2016;43(6):482–91. https://doi.org/10.1111/jcpe.12523.CrossRefPubMed

47.

Gomes-Filho IS. das Merces MC, de Santana Passos-Soares J, Seixas da Cruz S, Teixeira Ladeia AM, Trindade SC et al. severity of periodontitis and metabolic syndrome: is there an association? J Periodontol. 2016;87(4):357–66. https://doi.org/10.1902/jop.2015.150367.CrossRefPubMed

48.

Kaye EK, Chen N, Cabral HJ, Vokonas P, Garcia RI. Metabolic syndrome and periodontal disease progression in men. J Dent Res. 2016;95(7):822–8. https://doi.org/10.1177/0022034516641053.CrossRefPubMedPubMedCentral

49.

Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, Nishinoue N, et al. Association between the duration of periodontitis and increased Cardiometabolic risk factors: a 9-year cohort study. Metab Syndr Relat Disord. 2016;14(10):475–82. https://doi.org/10.1089/met.2016.0018.CrossRefPubMed

50.

Seraphim AP, Chiba FY, Pereira RF, Mattera MS, Moimaz SA, Sumida DH. Relationship among periodontal disease, insulin resistance, salivary cortisol, and stress levels during pregnancy. Braz Dent J. 2016;27(2):123–7. https://doi.org/10.1590/0103-6440201600596.CrossRefPubMed

51.

Tavakoli M, Izadi M, Yaghini J, Rastegari A, Abed AM. A survey on the effects of metabolic syndrome on the periodontal indices of hemodialysis patients. Dent Res J (Isfahan). 2016;13(4):333–7.CrossRef

52.

Alazawi W, Bernabe E, Tai D, Janicki T, Kemos P, Samsuddin S, et al. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLoS One. 2017;12(12):e0185902. https://doi.org/10.1371/journal.pone.0185902.CrossRefPubMedPubMedCentral

53.

Deshpande NC, Amrutiya MR. Obesity and oral health - is there a link? An observational study. J Indian Soc Periodontol. 2017;21(3):229–33. https://doi.org/10.4103/jisp.jisp_305_16.CrossRefPubMedPubMedCentral

54.

Drazewski D, Grzymislawska M, Korybalska K, Czepulis N, Grzymislawski M, Witowski J et al. Oral Health Status of Patients with Lysosomal Storage Diseases in Poland. Int J Environ Res Public Health. 2017;14(3). doi:https://doi.org/10.3390/ijerph14030281.CrossRefPubMedCentral

55.

Goulart AC, Armani F, Arap AM, Nejm T, Andrade JB, Bufarah HB, et al. Relationship between periodontal disease and cardiovascular risk factors among young and middle-aged Brazilians. Cross-sectional study Sao Paulo Med J. 2017;135(3):226–33. https://doi.org/10.1590/1516-3180.2016.0357300117.CrossRefPubMed

56.

Jaramillo A, Contreras A, Lafaurie GI, Duque A, Ardila CM, Duarte S, et al. Association of metabolic syndrome and chronic periodontitis in Colombians. Clin Oral Investig. 2017;21(5):1537–44. https://doi.org/10.1007/s00784-016-1942-9.CrossRefPubMed

57.

Kikui M, Kokubo Y, Ono T, Kida M, Kosaka T, Yamamoto M, et al. Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the Suita study. J Atheroscler Thromb. 2017;24(5):495–507. https://doi.org/10.5551/jat.33761.CrossRefPubMedPubMedCentral

58.

Kitagawa M, Kurahashi T, Matsukubo T. Relationship between general health, lifestyle, Oral health, and periodontal disease in adults: a large cross-sectional study in Japan. Bull Tokyo Dent Coll. 2017;58(1):1–8. https://doi.org/10.2209/tdcpublication.2016-2100.CrossRefPubMed

59.

Musskopf ML, Daudt LD, Weidlich P, Gerchman F, Gross JL, Oppermann RV. Metabolic syndrome as a risk indicator for periodontal disease and tooth loss. Clin Oral Investig. 2017;21(2):675–83. https://doi.org/10.1007/s00784-016-1935-8.CrossRefPubMed

60.

Popescu D, Gheorghe D, Puiu I, Rica AM. Odontal-Periodontal Changes in Patients with Type 1 Diabetes. Curr Health Sci J. 2017;43(4):330–4. doi:https://doi.org/10.12865/CHSJ.43.04.07.

61.

Sadeghi R, Taleghani F, Mohammadi S, Zohri Z. The effect of diabetes mellitus type I on periodontal and dental status. J Clin Diagn Res. 2017;11(7):ZC14–ZC7. https://doi.org/10.7860/JCDR/2017/25742.10153.CrossRefPubMedPubMedCentral

62.

Sfasciotti GL, Marini R, Pacifici A, Ierardo G, Pacifici L, Polimeni A. Childhood overweight-obesity and periodontal diseases: is there a real correlation? Ann Stomatol (Roma). 2016;7(3):65–72. doi:https://doi.org/10.11138/ads/2016.7.3.065.

63.

Song SJ, Lee SS, Han K, Park JB. Periodontitis is associated with diabetic retinopathy in non-obese adults. Endocrine. 2017;56(1):82–9. https://doi.org/10.1007/s12020-016-1215-z.CrossRefPubMed

64.

Vallogini G, Nobili V, Rongo R, De Rosa S, Magliarditi F, D'Anto V et al. Evaluation of the relationship between obesity, dental caries and periodontal disease in adolescents. Eur J Paediatr Dent. 2017;18(4):268–72. doi:https://doi.org/10.23804/ejpd.2017.18.04.02.

65.

Coelho A, Carneiro AS, Pereira VF, Paula AP, Macedo AP, Carrilho EVP. Oral Health of Portuguese Children with Type 1 Diabetes: A Multiparametric Evaluation. J Clin Pediatr Dent. 2018;42(3):231–5. doi:https://doi.org/10.17796/1053-4628-42.3.12.CrossRefPubMed

66.

Dhir S, Kumar V. Are cardiovascular risk parameters and glycemic levels associated with periodontitis in type 2 diabetes patients? A clinical study. Indian Heart J. 2018;70(3):430–2. https://doi.org/10.1016/j.ihj.2017.10.002.CrossRefPubMed

67.

Diaz Rosas CY, Cardenas Vargas E, Castaneda-Delgado JE, Aguilera-Galaviz LA, Aceves Medina MC. Dental, periodontal and salivary conditions in diabetic children associated with metabolic control variables and nutritional plan adherence. Eur J Paediatr Dent. 2018;19(2):119–26. doi:https://doi.org/10.23804/ejpd.2018.19.02.05.

68.

Kemer Dogan ES, Kirzioglu FY, Dogan B, Fentoglu O, Kale B. The effect of menopause on the relationship between hyperlipidemia and periodontal disease via salivary 8-hydroxy-2′-deoxyguanosine and myeloperoxidase levels. Acta Odontol Scand. 2018;76(2):92–7. https://doi.org/10.1080/00016357.2017.1386798.CrossRefPubMed

69.

Kim OS, Shin MH, Kweon SS, Lee YH, Kim OJ, Kim YJ, et al. The severity of periodontitis and metabolic syndrome in Korean population: the dong-gu study. J Periodontal Res. 2018;53(3):362–8. https://doi.org/10.1111/jre.12521.CrossRefPubMed

70.

Koo HS, Hong SM. Prevalence and risk factors for periodontitis among patients with metabolic syndrome. Metab Syndr Relat Disord. 2018;16(7):375–81. https://doi.org/10.1089/met.2018.0003.CrossRefPubMed

71.

Nascimento GG, Leite FRM, Peres KG, Demarco FF, Correa MB, Peres MA. Metabolic syndrome and periodontitis: a structural equation modeling approach. J Periodontol. 2019;90(6):655–62. https://doi.org/10.1002/JPER.18-0483.CrossRefPubMed

72.

Nibali L, Donos N, Terranova V, Di Pino A, Di Marca S, Ferrara V, et al. Left ventricular geometry and periodontitis in patients with the metabolic syndrome. Clin Oral Investig. 2019;23(6):2695–703. https://doi.org/10.1007/s00784-018-2667-8.CrossRefPubMed

73.

Pham T. The association between periodontal disease severity and metabolic syndrome in Vietnamese patients. Int J Dent Hyg. 2018;16(4):484–91. https://doi.org/10.1111/idh.12350.CrossRefPubMed

74.

Helenius-Hietala J, Suominen AL, Ruokonen H, Knuuttila M, Puukka P, Jula A, et al. Periodontitis is associated with incident chronic liver disease-a population-based cohort study. Liver Int. 2019;39(3):583–91. https://doi.org/10.1111/liv.13985.CrossRefPubMed

75.

Sakurai SI, Yamada SI, Karasawa I, Sakurai A, Kurita H. A longitudinal study on the relationship between dental health and metabolic syndrome in Japan. J Periodontol. 2019;90(7):728–46. https://doi.org/10.1002/JPER.18-0523.CrossRefPubMed

76.

Zhao D, Zhen Z, Pelekos G, Yiu KH, Jin L. Periodontal disease increases the risk for onset of systemic comorbidities in dental hospital attendees: an 18-year retrospective cohort study. J Periodontol. 2019;90(3):225–33. https://doi.org/10.1002/JPER.18-0224.CrossRefPubMed

77.

Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012;12:16. https://doi.org/10.1186/1471-230X-12-16.CrossRefPubMedPubMedCentral

78.

Lamster IB, Pagan M. Periodontal disease and the metabolic syndrome. Int Dent J. 2017;67(2):67–77. https://doi.org/10.1111/idj.12264.CrossRefPubMed

79.

Nitta H, Katagiri S, Nagasawa T, Izumi Y, Ishikawa I, Izumiyama H, et al. The number of microvascular complications is associated with an increased risk for severity of periodontitis in type 2 diabetes patients: results of a multicenter hospital-based cross-sectional study. J Diabetes Investig. 2017;8(5):677–86. https://doi.org/10.1111/jdi.12633.CrossRefPubMedPubMedCentral

80.

Albandar JM, Rams TE. Global epidemiology of periodontal diseases: an overview. Periodontology 2000. 2002;29:7–10.CrossRefPubMed

81.

D'Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93(10):3989–94. https://doi.org/10.1210/jc.2007-2522.CrossRefPubMed

82.

Vergnes JN. Treating periodontal disease may improve metabolic control in diabetics. Evidence-based dentistry. 2010;11(3):73–4. https://doi.org/10.1038/sj.ebd.6400734.CrossRefPubMed

83.

Borrell LN, Kunzel C, Lamster I, Lalla E. Diabetes in the dental office: using NHANES III to estimate the probability of undiagnosed disease. J Periodontal Res. 2007;42(6):559–65. https://doi.org/10.1111/j.1600-0765.2007.00983.x.CrossRefPubMed

84.

Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol. 2011;48(4):257–73. https://doi.org/10.1007/s00592-011-0333-6.CrossRefPubMedPubMedCentral

85.

Blasco-Baque V, Kemoun P, Loubieres P, Arnal JF, Gourdy P, Serino M, et al. Impact of type 2 diabetes on the development of periodontal disease in the mouse. Bull Group Int Rech Sci Stomatol Odontol. 2011;50(2):11–2.PubMed

86.

Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A et al. Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Mol Syst Biol. 2017;13(3):921. doi:https://doi.org/10.15252/msb.20167356.CrossRefPubMedPubMedCentral

87.

Veitenhansl M, Stegner K, Hierl FX, Dieterle C, Feldmeier H, Gutt B, et al. 40th EASD annual meeting of the European Association for the Study of diabetes : Munich, Germany, 5-9 September 2004. Diabetologia. 2004;47(Suppl 1):A1–A464. https://doi.org/10.1007/BF03375463.CrossRef

88.

Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008;87(5):1219–23.CrossRefPubMed

89.

Courbon G, Rinaudo-Gaujous M, Blasco-Baque V, Auger I, Caire R, Mijola L, et al. Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat. Ann Rheum Dis. 2019. https://doi.org/10.1136/annrheumdis-2018-213697.CrossRefPubMed

90.

Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci. 2007;12:3965–74.CrossRefPubMed

91.

Burcelin R, Garidou L, Pomie C. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Semin Immunol. 2012;24(1):67–74. https://doi.org/10.1016/j.smim.2011.11.011.CrossRefPubMed

92.

Burcelin R. Gut microbiota and immune crosstalk in metabolic disease. Mol Metab. 2016;5(9):771–81. https://doi.org/10.1016/j.molmet.2016.05.016.CrossRefPubMedPubMedCentral

93.

Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4592–8. https://doi.org/10.1073/pnas.1011383107.CrossRefPubMed

94.

Darré L, Vergnes J-N, Gourdy P, Sixou M. Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies. Diabetes Metab. 2008;34:497–506.CrossRefPubMed

95.

Grossi S. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol. 2001;6:138–45.CrossRefPubMed

96.

Miller L, Manwell M, Newbold D, Reding M, Rasheed A, Blodgett J. The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol. 1992;63:843–8.CrossRefPubMed

97.

Vergnes JN, Canceill T, Vinel A, Laurencin-Dalicieux S, Maupas-Schwalm F, Blasco-Baque V, et al. The effects of periodontal treatment on diabetic patients: the DIAPERIO randomized controlled trial. J Clin Periodontol. 2018. https://doi.org/10.1111/jcpe.13003.CrossRefPubMed

98.

Rosier BT, Marsh PD, Mira A. Resilience of the Oral microbiota in health: mechanisms that prevent Dysbiosis. J Dent Res. 2018;97(4):371–80. https://doi.org/10.1177/0022034517742139.CrossRefPubMed

99.

Fang D, Shi D, Lv L, Gu S, Wu W, Chen Y, et al. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci Rep. 2017;7(1):8770. https://doi.org/10.1038/s41598-017-09395-8.CrossRefPubMedPubMedCentral

100.

Wang L, Wu Y, Zhuang L, Chen X, Min H, Song S, et al. Puerarin prevents high-fat diet-induced obesity by enriching Akkermansia muciniphila in the gut microbiota of mice. PLoS One. 2019;14(6):e0218490. https://doi.org/10.1371/journal.pone.0218490.CrossRefPubMedPubMedCentral

101.

Schneeberger M, Everard A, Gomez-Valades AG, Matamoros S, Ramirez S, Delzenne NM, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643. https://doi.org/10.1038/srep16643.CrossRefPubMedPubMedCentral

102.

Moya-Perez A, Neef A, Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PLoS One. 2015;10(7):e0126976. https://doi.org/10.1371/journal.pone.0126976.CrossRefPubMedPubMedCentral

103.

Berridge MJ. Vitamin D deficiency and diabetes. Biochem J 2017;474(8):1321–1332. doi:https://doi.org/10.1042/BCJ20170042.CrossRefPubMed

104.

Cai T, Yang ZY, Nie L, Zhen JX, Deng L, Zhou Z. Association between vitamin D receptor BsmI gene polymorphism and periodontitis: a meta-analysis in a single ethnic group. Cell Mol Biol (Noisy-le-grand). 2017;63(11):1–4. doi:https://doi.org/10.14715/cmb/2017.63.11.1.CrossRefPubMed

105.

Ratheesh V, Subramanian S, Prakash PSG, Victor DJ. Evaluation of Association of Vitamin D Receptor Genetic Polymorphism with severe chronic periodontitis in an ethnic Tamilian population. Genet Test Mol Biomarkers. 2018;22(10):615–21. https://doi.org/10.1089/gtmb.2018.0190.CrossRefPubMed

106.

Murthykumar K, Arjunkumar R, Jayaseelan VP. Association of vitamin D receptor gene polymorphism (rs10735810) and chronic periodontitis. J Investig Clin Dent. 2019:e12440. doi:https://doi.org/10.1111/jicd.12440.

107.

Zhu A, Chen J, Wu P, Luo M, Zeng Y, Liu Y, et al. Cationic polystyrene resolves nonalcoholic Steatohepatitis, obesity, and metabolic disorders by promoting Eubiosis of gut microbiota and decreasing Endotoxemia. Diabetes. 2017;66(8):2137–43. https://doi.org/10.2337/db17-0070.CrossRefPubMedPubMedCentral

Title: Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases
Authors: Matthieu Minty
Thibault Canceil
Matteo Serino
Remy Burcelin
François Tercé
Vincent Blasco-Baque
Publication date: 01-12-2019
Publisher: Springer US
Keywords: Insulins
Oral Microbiota
Gingival Diseases
Respiratory Microbiota
Insulins
Published in: Reviews in Endocrine and Metabolic Disorders / Issue 4/2019
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-019-09526-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2019

The gut microbiome and heart failure: A better gut for a better heart

Microbiota impacts on chronic inflammation and metabolic syndrome - related cognitive dysfunction

Gut microbiota-derived succinate: Friend or foe in human metabolic diseases?

Gut microbiome and cardiometabolic risk

Consider the microbiome in the equation! They were here before us...and hosted us!

Dietary lipids, gut microbiota and lipid metabolism

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page